These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19587802)
1. Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis. Fleming JN; Shulman HM; Nash RA; Johnson PY; Wight TN; Gown A; Schwartz SM PLoS One; 2009 Jul; 4(7):e6203. PubMed ID: 19587802 [TBL] [Abstract][Full Text] [Related]
2. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404 [TBL] [Abstract][Full Text] [Related]
12. A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis. Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S PLoS One; 2012; 7(2):e32272. PubMed ID: 22384200 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease. Yang H; Cheong S; He Y; Lu F Stem Cell Res Ther; 2023 Dec; 14(1):372. PubMed ID: 38111001 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis. Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. Manetti M; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M J Cell Mol Med; 2010 Jun; 14(6A):1241-54. PubMed ID: 20132409 [TBL] [Abstract][Full Text] [Related]
16. Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis. Ponsoye M; Frantz C; Ruzehaji N; Nicco C; Elhai M; Ruiz B; Cauvet A; Pezet S; Brandely ML; Batteux F; Allanore Y; Avouac J Ann Rheum Dis; 2016 Dec; 75(12):2142-2149. PubMed ID: 26912566 [TBL] [Abstract][Full Text] [Related]
17. Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis. Yin H; Distler O; Shen L; Xu X; Yuan Y; Li R; Liu B; Li Q; Huang Q; Xie F; Zhang Z; Liang R; Dai X; Chen X; Li B; Yan Q; Lu L Arthritis Rheumatol; 2024 Jan; 76(1):78-91. PubMed ID: 37488975 [TBL] [Abstract][Full Text] [Related]
18. Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis. Romano E; Manetti M; Rosa I; Fioretto BS; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S Ann Rheum Dis; 2018 Nov; 77(11):1665-1674. PubMed ID: 30021803 [TBL] [Abstract][Full Text] [Related]
19. Vascular leak is a central feature in the pathogenesis of systemic sclerosis. Frech TM; Revelo MP; Drakos SG; Murtaugh MA; Markewitz BA; Sawitzke AD; Li DY J Rheumatol; 2012 Jul; 39(7):1385-91. PubMed ID: 22660809 [TBL] [Abstract][Full Text] [Related]
20. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis. Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]